Advanced Renal Cell Carcinoma

Evaluating Effectiveness, Safety of Lenvatinib, Everolimus in Patients With Advanced RCC
Current research is lacking in effective treatment strategies for patients with heavily pretreated metastatic renal cell carcinoma (mRCC). A study from Sebastiano Buti, MD, PhD, and colleagues published in Therapeutic Advances in Urology sought to determine the effectiveness and safety of lenvatinib plus everolimus for patients with mRCC. ...
Advertisement

Latest News

Advertisement

Knowledge Hub Spotlights

Curated clinical content based on conditions, therapies, and technologies

Renal Cell Carcinoma
Renal Cell Carcinoma

Conference Coverage

Advertisement
Section Editor

Advertisement
Get the latest RCC research straight to your inbox.